Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 14 | $59.01 | $826.18 |
DisclosureSEC source: 0001562180-21-003285 · primarydocument.xml · nonDerivative · entry 3 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,984 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $57.67 to $58.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 18,466 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 93 | $58.16 | $5,408.80 |
DisclosureSEC source: 0001562180-21-003285 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,998 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $58.75 to $59.45. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 18,466 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 119 | $57.25 | $6,812.40 |
DisclosureSEC source: 0001562180-21-003285 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,091 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $56.67 to $57.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 18,466 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 6 | $61.36 | $368.16 |
DisclosureSEC source: 0001562180-21-003283 · primarydocument.xml · nonDerivative · entry 4 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,222 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 573 RSUs. F3 · balance_after: Includes 20,930 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 11 | $59.01 | $649.14 |
DisclosureSEC source: 0001562180-21-003283 · primarydocument.xml · nonDerivative · entry 3 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,228 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 573 RSUs. F5 · price: This transaction was executed in multiple trades at prices ranging from $58.75 to $59.45. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 20,930 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 71 | $58.16 | $4,129.30 |
DisclosureSEC source: 0001562180-21-003283 · primarydocument.xml · nonDerivative · entry 2 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,239 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 573 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $57.67 to $58.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 20,930 restricted stock units. Read SEC document |
| May 03, 2021 Filed May 6, 2021 01:15 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 90 | $57.25 | $5,152.24 |
DisclosureSEC source: 0001562180-21-003283 · primarydocument.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,310 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 573 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $56.67 to $57.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 20,930 restricted stock units. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 21:18 UTC |
OLSON LAURIE JDirector
|
GrantStock Option (right to buy) · Derivative | 15,800 | $0.00 Strike: $77.79 | $0.00 |
DisclosureSEC source: 0001562180-21-003003 · primarydocument.xml · derivative · entry 2 OLSON LAURIE J · CIK 0001553231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,800 Underlying: Common Stock · 15,800 shares Expires 2031-04-27 F3 · derivative.exercise_date: The option vests as to one-third of the shares on April 27, 2022, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 21:18 UTC |
OLSON LAURIE JDirector
|
GrantCommon Stock | 4,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003003 · primarydocument.xml · nonDerivative · entry 1 OLSON LAURIE J · CIK 0001553231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,540 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of shares on each of April 27, 2022, April 27, 2023 and April 27, 2024. F2 · balance_after: Includes 4,540 restricted stock units. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 16:05 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,300 | $58.65 | $134,903.74 |
DisclosureSEC source: 0001562180-21-002907 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975,568 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $58.24 to $59.20. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 121,049 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 16:05 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,700 | $57.87 | $156,238.20 |
DisclosureSEC source: 0001562180-21-002907 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977,868 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $57.42 to $58.40. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 121,049 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 15, 2021 Filed Apr 15, 2021 20:59 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $62.14 | $103,587.38 |
DisclosureSEC source: 0001562180-21-002823 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,618 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 10,947 restricted stock units. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 16:02 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,600 | $65.75 | $236,690.64 |
DisclosureSEC source: 0001562180-21-002765 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980,568 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $65.595 to $65.86. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 121,049 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 16:02 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,400 | $65.01 | $91,012.46 |
DisclosureSEC source: 0001562180-21-002765 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 984,168 F1 · shares: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $64.56 to $65.51. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 121,049 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 01, 2021 Filed Apr 3, 2021 01:45 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 223 | $61.45 | $13,703.35 |
DisclosureSEC source: 0001562180-21-002586 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,430 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:43 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 193 | $61.45 | $11,859.85 |
DisclosureSEC source: 0001562180-21-002584 · primarydocument.xml · nonDerivative · entry 1 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,461 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2021. F3 · balance_after: Includes 5,297 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 3, 2021 01:44 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 294 | $61.45 | $18,066.30 |
DisclosureSEC source: 0001562180-21-002585 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,690 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 3, 2021 01:43 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 211 | $61.45 | $12,965.95 |
DisclosureSEC source: 0001562180-21-002583 · primarydocument.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,637 F1 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2021. F2 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2021. F3 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 16:07 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 15 | $63.36 | $950.40 |
DisclosureSEC source: 0001562180-21-002633 · primarydocument.xml · nonDerivative · entry 3 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,832 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F3 · balance_after: Includes 23,770 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 16:07 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 126 | $62.70 | $7,900.00 |
DisclosureSEC source: 0001562180-21-002633 · primarydocument.xml · nonDerivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,847 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $62.30 to $63.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 23,770 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 16:07 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 60 | $61.92 | $3,715.18 |
DisclosureSEC source: 0001562180-21-002633 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,973 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.30 to $62.27. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 23,770 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 16:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 260 | $63.36 | $16,473.60 |
DisclosureSEC source: 0001562180-21-002634 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 985,568 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F3 · balance_after: Includes 121,049 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 16:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,148 | $62.70 | $134,676.16 |
DisclosureSEC source: 0001562180-21-002634 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 985,828 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $62.30 to $63.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 121,049 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 16:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,024 | $61.92 | $63,405.67 |
DisclosureSEC source: 0001562180-21-002634 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987,976 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.30 to $62.27. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 121,049 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:46 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 16 | $63.36 | $1,013.76 |
DisclosureSEC source: 0001562180-21-002660 · primarydocument.xml · nonDerivative · entry 3 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,210 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F3 · balance_after: Includes 19,216 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:46 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 135 | $62.70 | $8,464.28 |
DisclosureSEC source: 0001562180-21-002660 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,226 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $62.30 to $63.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,216 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:46 UTC |
Mattoon DawnSr. VP, Diagnostics
|
SaleCommon Stock | 64 | $61.92 | $3,962.85 |
DisclosureSEC source: 0001562180-21-002660 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,361 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 750 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.30 to $62.27. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,216 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:07 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 13 | $63.36 | $823.68 |
DisclosureSEC source: 0001562180-21-002632 · primarydocument.xml · nonDerivative · entry 3 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,400 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 573 RSUs. F3 · balance_after: Includes 21,503 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:07 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 103 | $62.70 | $6,457.94 |
DisclosureSEC source: 0001562180-21-002632 · primarydocument.xml · nonDerivative · entry 2 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,413 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 573 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $62.30 to $63.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 21,503 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:07 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 49 | $61.92 | $3,034.06 |
DisclosureSEC source: 0001562180-21-002632 · primarydocument.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,516 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 573 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.30 to $62.27. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 21,503 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:46 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 10 | $63.36 | $633.60 |
DisclosureSEC source: 0001562180-21-002659 · primarydocument.xml · nonDerivative · entry 3 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,436 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F3 · balance_after: Includes 14,709 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:46 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 85 | $62.70 | $5,329.36 |
DisclosureSEC source: 0001562180-21-002659 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,446 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $62.30 to $63.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,709 restricted stock units. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:46 UTC |
Roskey Mark T.SVP, Strategic Partnerships
|
SaleCommon Stock | 41 | $61.92 | $2,538.70 |
DisclosureSEC source: 0001562180-21-002659 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,531 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 472 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.30 to $62.27. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,709 restricted stock units. Read SEC document |
| April 01, 2021 Filed Jul 6, 2021 21:17 UTC Amendment |
CRANDELL KEITHDirector
|
GrantCommon Stock | 211 | $61.45 | $12,965.95 |
DisclosureSEC source: 0001104659-21-089483 · tm2121524-1_4aseq1.xml · nonDerivative · entry 7 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,924 F6 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2021. F7 · price: Closing price of the Company's common stock on the Nasdaq Global Market on April 1, 2021. F8 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| March 19, 2021 Filed Mar 19, 2021 20:03 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $58.36 | $97,286.12 |
DisclosureSEC source: 0001562180-21-002370 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,285 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 11,313 restricted stock units. Read SEC document |
| March 16, 2021 Filed Mar 16, 2021 17:30 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 4,100 | $61.51 | $252,211.09 |
DisclosureSEC source: 0001562180-21-002265 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 989,000 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $61.20 to $61.72. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,984 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 16, 2021 Filed Mar 16, 2021 17:30 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 900 | $60.42 | $54,380.70 |
DisclosureSEC source: 0001562180-21-002265 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,100 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $60.08 to $60.74. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,984 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 12, 2021 Filed Jul 6, 2021 21:17 UTC Amendment |
CRANDELL KEITHDirector
|
OtherCommon Stock | 13,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089483 · tm2121524-1_4aseq1.xml · nonDerivative · entry 6 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,713 F1 · kind: This amended Form 4 is being filed solely to correct the inadvertent omission of details concerning changes in the form of beneficial ownership of these securities by the Reporting Person as a result of pro rata distributions of shares by ARCH Venture Fund VI, L.P. ("ARCH VI") and ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"), which took place in March 2021. F2 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F5 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. F2 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. Read SEC document |
| March 12, 2021 Filed Jul 6, 2021 21:17 UTC Amendment |
CRANDELL KEITHDirector
|
OtherCommon Stock | 165,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089483 · tm2121524-1_4aseq1.xml · nonDerivative · entry 5 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 883,850 F1 · kind: This amended Form 4 is being filed solely to correct the inadvertent omission of details concerning changes in the form of beneficial ownership of these securities by the Reporting Person as a result of pro rata distributions of shares by ARCH Venture Fund VI, L.P. ("ARCH VI") and ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"), which took place in March 2021. F2 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · ownership.nature: These shares are directly held by ARCH Overage. ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 12, 2021 Filed Jul 6, 2021 21:17 UTC Amendment |
CRANDELL KEITHDirector
|
OtherCommon Stock | 259,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089483 · tm2121524-1_4aseq1.xml · nonDerivative · entry 4 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,386,400 F1 · kind: This amended Form 4 is being filed solely to correct the inadvertent omission of details concerning changes in the form of beneficial ownership of these securities by the Reporting Person as a result of pro rata distributions of shares by ARCH Venture Fund VI, L.P. ("ARCH VI") and ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"), which took place in March 2021. F2 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH VI. ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 09, 2021 Filed Jul 6, 2021 21:17 UTC Amendment |
CRANDELL KEITHDirector
|
OtherCommon Stock | 13,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089483 · tm2121524-1_4aseq1.xml · nonDerivative · entry 3 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,069 F1 · kind: This amended Form 4 is being filed solely to correct the inadvertent omission of details concerning changes in the form of beneficial ownership of these securities by the Reporting Person as a result of pro rata distributions of shares by ARCH Venture Fund VI, L.P. ("ARCH VI") and ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"), which took place in March 2021. F2 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F5 · kind: Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person. F2 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. Read SEC document |
| March 09, 2021 Filed Jul 6, 2021 21:17 UTC Amendment |
CRANDELL KEITHDirector
|
OtherCommon Stock | 165,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089483 · tm2121524-1_4aseq1.xml · nonDerivative · entry 2 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,049,310 F1 · kind: This amended Form 4 is being filed solely to correct the inadvertent omission of details concerning changes in the form of beneficial ownership of these securities by the Reporting Person as a result of pro rata distributions of shares by ARCH Venture Fund VI, L.P. ("ARCH VI") and ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"), which took place in March 2021. F2 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F4 · ownership.nature: These shares are directly held by ARCH Overage. ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 09, 2021 Filed Jul 6, 2021 21:17 UTC Amendment |
CRANDELL KEITHDirector
|
OtherCommon Stock | 259,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-089483 · tm2121524-1_4aseq1.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,645,940 F1 · kind: This amended Form 4 is being filed solely to correct the inadvertent omission of details concerning changes in the form of beneficial ownership of these securities by the Reporting Person as a result of pro rata distributions of shares by ARCH Venture Fund VI, L.P. ("ARCH VI") and ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"), which took place in March 2021. F2 · kind: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F2 · price: Distribution of Common Stock held by a limited partnership to its partners for no consideration. F3 · ownership.nature: These shares are directly held by ARCH VI. ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:09 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 800 | $68.00 | $54,400.00 |
DisclosureSEC source: 0001562180-21-002145 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994,000 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F3 · balance_after: Includes 128,984 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:09 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 320 | $67.05 | $21,454.50 |
DisclosureSEC source: 0001562180-21-002145 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994,800 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $67.00 to $67.11. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,984 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:09 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,780 | $66.26 | $184,190.57 |
DisclosureSEC source: 0001562180-21-002145 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 995,120 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $66.00 to $66.90. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,984 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:09 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,100 | $64.53 | $70,983.00 |
DisclosureSEC source: 0001562180-21-002145 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 997,900 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $64.05 to $65.01. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,984 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:07 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 15 | $81.82 | $1,227.23 |
DisclosureSEC source: 0001562180-21-001905 · primarydocument.xml · nonDerivative · entry 2 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,033 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $81.69 to $81.93. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 24,470 restricted stock units. Also includes 705 shares acquired under the Quanterix Corporation Employee Stock Purchase Plan on February 26, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:07 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 187 | $81.29 | $15,201.04 |
DisclosureSEC source: 0001562180-21-001905 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,048 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 700 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.69 to $81.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 24,470 restricted stock units. Also includes 705 shares acquired under the Quanterix Corporation Employee Stock Purchase Plan on February 26, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:08 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 259 | $81.82 | $21,190.09 |
DisclosureSEC source: 0001562180-21-001906 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999,000 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $81.69 to $81.93. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,984 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.